Home | Careers | Contact Us | Sitemap 
   Other Country Sites Search
Generic FAQs
 
Home > Newsroom  
 January 2012
 
 Day : 25
RANBAXY ANNOUNCES COURT FILING OF CONSENT DECREE WITH U.S. FOOD AND DRUG ADMINISTRATION
 
 December 2011
 
 Day : 21
RANBAXY ANNOUNCES CONSENT DECREE WITH U.S. FOOD AND DRUG ADMINISTRATION TAKES CORRECTIVE STEPS, COMMITS TO FURTHER MEASURES
 
 Day : 6
RANBAXY LAUNCHES AUTHORIZED GENERIC VERSION OF CADUET® IN THE U.S.
 
 Day : 1
RANBAXY ANNOUNCES LAUNCH OF ATORVASTATIN, GENERIC LIPITOR®, IN THE U.S.
 
 October 2011
 
 Day : 11
Ranbaxy Honored With NJBIA Award for Excellence in New Jersey Business Expansion
 
 
 August 2011
 
 Day : 31
Lt. Governor Kim Guadagno visits Ranbaxy’s manufacturing facility, Ohm Laboratories
 
 
 July 2011
 
 Day : 12
Ranbaxy enters into a licensing agreement with Gilead Sciences to manufacture and market three anti-HIV drugs in India and developing countries
 
 Day : 1
Ranbaxy to Decommission Gloversville, NY Facility
 
 
 November 2010
 
 Day : 30
Ranbaxy Launches Donepezil 5 Mg and 10 Mg Tablets to U.S. Healthcare System
 
 
 March 2010
 
 Day : 15
Ranbaxy Announces Settlement Of Actos® (Pioglitazone Hydrochloride) Patent Litigation
 
 
 September 2009
 
 Day : 2
Ranbaxy Launches Authorized Generic Version Of Rocaltrol®
 
 
 August 2009
 
 Day : 24
Ranbaxy Receives Final Approval To Manufacture And Market Glycopyrrolate Tablets
 
 
 Day : 11
Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets
 
 
  May 2009
 
 Day : 1
Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules In The U.S.
 
 
 March 2009
 
 Day : 5
Ranbaxy Secures Final FDA Approval For Quinapril Hydrochloride + Hydrochlorothiazide Tablets
 
 
 February 2009
 
 Day : 26
Press Statement
 
 
 September 2008
 
 Day : 17
Ranbaxy Laboratories, Ltd., Retains former New York City Mayor Rudy Giuliani to lead team in resolution of issues raised by U. S. Food & Drug Administration
 
 
 July 2008
 
 Day : 28
Ranbaxy launches Omeprazole 40 mg capsules
 
 
 June 2008
 
 Day : 25
Ranbaxy gains tentative approval to manufacture and market Valganciclovir Hydrochloride tablets
 
 Day : 18
Ranbaxy and Pfizer settle Lipitor Litigation worldwide
 
 Day : 11
Ranbaxy to bring in Daiichi Sankyo Company Limited as Majority Partner
 
 
 April 2008
 
 Day : 15
Ranbaxy and AstraZeneca reach agreement in esomeprazole patent litigation
 
 
 February 2008
 
 Day : 7
Ranbaxy receives tentative approval to manufacture and market Esomeprazole Magnesium dr capsules
 
 Day : 6
Ranbaxy gains approval to manufacture and market Cefuroxime axetil for oral suspension
 
 
 November 2007
 
 Day : 8
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
 
 
October 2007
 
Day : 29
Ranbaxy Receives Tentative Approval for Valsartan Tablets
 
Day : 2
Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
 

Media Contacts

Chuck Caprariello
Vice President, Corporate Communications and Government Affairs
Phone: (609)720-5615
chuck.caprariello@ranbaxy.com